Inventor
FRAYSSE DAMIEN
GB50 patents
⚠️ This page may combine multiple inventors who share the name “FRAYSSE DAMIEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
29 patentsUS7820685B2Oct 26, 2010
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA51 citations98
US7767672B2Aug 3, 2010
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA51 citations98
US7528142B2May 5, 2009
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA67 citations98
US7507826B2Mar 24, 2009
Azaindoles useful as inhibitors of JAK and other protein kinases
VERTEX PHARMA55 citations98
US9340546B2May 17, 2016
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA57 citations97
US9718827B2Aug 1, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA22 citations93
US7795259B2Sep 14, 2010
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
VERTEX PHARMA28 citations93
US9650381B2May 16, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA19 citations92
US8987454B2Mar 24, 2015
Azaindoles useful as inhibitors of JAK and other protein kinases
VERTEX PHARMA19 citations92
US8969360B2Mar 3, 2015
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA25 citations92
US8722889B2May 13, 2014
Azaindoles useful as inhibitors of JAK and other protein kinases
VERTEX PHARMA22 citations92
US10787452B2Sep 29, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA5 citations84
US10392391B2Aug 27, 2019
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA4 citations84
US9670215B2Jun 6, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA11 citations84
US8957078B2Feb 17, 2015
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA19 citations84
US8372835B2Feb 12, 2013
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
VERTEX PHARMA17 citations84
US11370798B2Jun 28, 2022
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA1 citations73
US11117900B2Sep 14, 2021
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA2 citations73
US10800781B2Oct 13, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA2 citations73
US10093676B2Oct 9, 2018
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations73
US10815239B2Oct 27, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations71
US10160760B2Dec 25, 2018
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations71
US12187731B2Jan 7, 2025
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations62
US11485739B2Nov 1, 2022
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations60
US9193722B2Nov 24, 2015
Tri-cyclic pyrazolopyridine kinase inhibitors
VERTEX PHARMA0 citations52
US9029546B2May 12, 2015
Pyrazolopyridine kinase inhibitors
VERTEX PHARMA0 citations52
US8815866B2Aug 26, 2014
Aminopyridine kinase inhibitors
VERTEX PHARMA0 citations52
US8377926B2Feb 19, 2013
Aminopyridine kinase inhibitors
VERTEX PHARMA1 citations52
US9663519B2May 30, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations42
JIMENEZ JUAN-MIGUEL
5 patentsUS8569337B2Oct 29, 2013
Tri-cyclic pyrazolopyridine kinase inhibitors
JIMENEZ JUAN-MIGUEL19 citations92
US8188071B2May 29, 2012
Amino substituted pyridines as potent kinase inhibitors
JIMENEZ JUAN-MIGUEL12 citations84
US8741931B2Jun 3, 2014
Kinase inhibitors
JIMENEZ JUAN-MIGUEL4 citations71
US8895740B2Nov 25, 2014
Pyrazolopyrazine kinase inhibitors
JIMENEZ JUAN-MIGUEL0 citations38
US8809335B2Aug 19, 2014
Pyrazolopyrimidine kinase inhibitors
JIMENEZ JUAN-MIGUEL0 citations38
BINCH HAYLEY
3 patentsMERCK PATENT GMBH
3 patentsAIRBUS OPERATIONS SAS
3 patentsUS9630722B2Apr 25, 2017
Support for routing conduits in an aircraft wing
AIRBUS OPERATIONS SAS1 citations50
US9791070B2Oct 17, 2017
Device and method for fitting two connections at the end of two conduits, in particular in an aircraft
AIRBUS OPERATIONS SAS1 citations44
US9546623B2Jan 17, 2017
Assembly device for double-skinned aircraft fuel pipes
AIRBUS OPERATIONS SAS0 citations34